$ANDS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANADYS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ANADYS PHARMACEUTICALS INC. Get notifications about new insider transactions in ANADYS PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.68 | 364,918 | 1,342,898 | 5,152,936 | 5.5 M to 5.2 M (-6.61 %) |
Oct 24 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.68 | 5,252,700 | 19,329,936 | 5,517,854 | 10.8 M to 5.5 M (-48.77 %) |
Oct 19 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.68 | 650,100 | 2,392,368 | 10,770,554 | 11.4 M to 10.8 M (-5.69 %) |
Aug 24 2011 | ANDS | ANADYS PHARMACEUTI ... | Posner Brian S | Director | Option Exercise | A | 0.70 | 25,000 | 17,500 | 25,000 | |
May 27 2011 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 1.17 | 15,000 | 17,550 | 15,000 | |
May 27 2011 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 1.17 | 15,000 | 17,550 | 15,000 | |
May 27 2011 | ANDS | ANADYS PHARMACEUTI ... | Labinger Barry | Director | Option Exercise | A | 1.17 | 3,205 | 3,750 | 3,205 | |
May 27 2011 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 1.17 | 15,000 | 17,550 | 15,000 | |
May 27 2011 | ANDS | ANADYS PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 1.17 | 15,000 | 17,550 | 15,000 | |
Mar 15 2011 | ANDS | ANADYS PHARMACEUTI ... | Labinger Barry | Director | Option Exercise | A | 1.24 | 25,000 | 31,000 | 25,000 | |
Jan 24 2011 | ANDS | ANADYS PHARMACEUTI ... | Slover Peter T | VP, Finance and Ope ... | Option Exercise | A | 1.29 | 50,000 | 64,500 | 50,000 | |
Jan 24 2011 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | SVP, Legal Affairs ... | Option Exercise | A | 1.29 | 50,000 | 64,500 | 50,000 | |
Jan 24 2011 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | SVP, Drug Developme ... | Option Exercise | A | 1.29 | 50,000 | 64,500 | 50,000 | |
Jan 24 2011 | ANDS | ANADYS PHARMACEUTI ... | Eastwood Kevin L. | SVP, Corporate Deve ... | Option Exercise | A | 1.29 | 25,000 | 32,250 | 25,000 | |
Jan 24 2011 | ANDS | ANADYS PHARMACEUTI ... | Appleman James R. | SVP, Research & CSO | Option Exercise | A | 1.29 | 50,000 | 64,500 | 50,000 | |
Jan 05 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.41 | 34,209 | 48,235 | 11,420,654 | 11.4 M to 11.4 M (+0.30 %) |
Jan 03 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.48 | 300 | 444 | 11,386,445 | 11.4 M to 11.4 M (0.00 %) |
Jan 03 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.45 | 267,014 | 387,170 | 11,386,145 | 11.1 M to 11.4 M (+2.40 %) |
Jan 03 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.46 | 50,000 | 73,000 | 11,119,131 | 11.1 M to 11.1 M (+0.45 %) |
Dec 29 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.44 | 532,490 | 766,786 | 11,069,131 | 10.5 M to 11.1 M (+5.05 %) |
Dec 29 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.34 | 12,200 | 16,348 | 10,536,641 | 10.5 M to 10.5 M (+0.12 %) |
Dec 29 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.30 | 1,714,210 | 2,228,473 | 10,524,441 | 8.8 M to 10.5 M (+19.46 %) |
Dec 27 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.21 | 285,790 | 345,806 | 8,810,231 | 8.5 M to 8.8 M (+3.35 %) |
Dec 15 2010 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 1.02 | 300,000 | 306,000 | 300,000 | |
Dec 15 2010 | ANDS | ANADYS PHARMACEUTI ... | Slover Peter T | VP, Finance and Ope ... | Option Exercise | A | 1.02 | 51,750 | 52,785 | 51,750 | |
Dec 15 2010 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | SVP, Legal Affairs ... | Option Exercise | A | 1.02 | 68,625 | 69,998 | 68,625 | |
Dec 15 2010 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | SVP, Drug Developme ... | Option Exercise | A | 1.02 | 71,438 | 72,867 | 71,438 | |
Oct 22 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.65 | 150,000 | 247,500 | 8,524,441 | 8.4 M to 8.5 M (+1.79 %) |
Oct 19 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.65 | 150,000 | 247,500 | 8,374,441 | 8.2 M to 8.4 M (+1.82 %) |
Oct 19 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.66 | 85,000 | 141,100 | 8,224,441 | 8.1 M to 8.2 M (+1.04 %) |
Oct 19 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.67 | 25,000 | 41,750 | 8,139,441 | 8.1 M to 8.1 M (+0.31 %) |
Oct 19 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.68 | 90,000 | 151,200 | 8,114,441 | 8 M to 8.1 M (+1.12 %) |
Oct 19 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.80 | 1,951,389 | 3,512,500 | 8,024,441 | 6.1 M to 8 M (+32.13 %) |
Sep 14 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.80 | 25,000 | 45,000 | 6,065,052 | 6 M to 6.1 M (+0.41 %) |
Sep 20 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.78 | 8,000 | 14,240 | 6,073,052 | 6.1 M to 6.1 M (+0.13 %) |
Sep 03 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.74 | 25,000 | 43,500 | 6,040,052 | 6 M to 6 M (+0.42 %) |
Aug 31 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.77 | 25,000 | 44,250 | 6,015,052 | 6 M to 6 M (+0.42 %) |
Aug 31 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.75 | 6,000 | 10,500 | 5,990,052 | 6 M to 6 M (+0.10 %) |
Aug 27 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.75 | 15,700 | 27,475 | 5,984,052 | 6 M to 6 M (+0.26 %) |
Aug 27 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.70 | 17,400 | 29,580 | 5,968,352 | 6 M to 6 M (+0.29 %) |
Aug 25 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.73 | 34,900 | 60,377 | 5,950,952 | 5.9 M to 6 M (+0.59 %) |
Aug 25 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.79 | 27,000 | 48,330 | 5,916,052 | 5.9 M to 5.9 M (+0.46 %) |
Aug 23 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.77 | 4,000 | 7,080 | 5,889,052 | 5.9 M to 5.9 M (+0.07 %) |
Aug 23 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.79 | 16,000 | 28,640 | 5,885,052 | 5.9 M to 5.9 M (+0.27 %) |
Aug 18 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.80 | 5,000 | 9,000 | 5,869,052 | 5.9 M to 5.9 M (+0.09 %) |
Aug 18 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.86 | 35,000 | 65,100 | 5,864,052 | 5.8 M to 5.9 M (+0.60 %) |
Aug 16 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.94 | 32,500 | 63,050 | 5,829,052 | 5.8 M to 5.8 M (+0.56 %) |
Aug 05 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.99 | 50,400 | 100,296 | 5,796,552 | 5.7 M to 5.8 M (+0.88 %) |
Jul 08 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.98 | 30,000 | 59,400 | 5,746,152 | 5.7 M to 5.7 M (+0.52 %) |
Jul 06 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.94 | 56,800 | 110,192 | 5,716,152 | 5.7 M to 5.7 M (+1.00 %) |
May 28 2010 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.30 | 15,000 | 34,500 | 15,000 | |
May 28 2010 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Option Exercise | A | 2.30 | 15,000 | 34,500 | 15,000 | |
May 28 2010 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 2.30 | 15,000 | 34,500 | 15,000 | |
May 28 2010 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 2.30 | 15,000 | 34,500 | 15,000 | |
May 28 2010 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 2.30 | 15,000 | 34,500 | 15,000 | |
May 28 2010 | ANDS | ANADYS PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 2.30 | 15,000 | 34,500 | 15,000 | |
Dec 07 2009 | ANDS | ANADYS PHARMACEUTI ... | Slover Peter T | VP, Finance and Ope ... | Option Exercise | A | 2.42 | 53,086 | 128,468 | 53,086 | |
Dec 07 2009 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 2.42 | 165,150 | 399,663 | 165,150 | |
Dec 07 2009 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | SVP, Legal Affairs ... | Option Exercise | A | 2.42 | 72,863 | 176,328 | 72,863 | |
Dec 07 2009 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | SVP, Drug Developme ... | Option Exercise | A | 2.42 | 73,500 | 177,870 | 73,500 | |
Oct 06 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | J | 2.32 | 7,500 | 17,400 | 7,500 | |
Oct 06 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | J | 2.73 | 7,500 | 20,475 | 7,500 | |
Oct 06 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | J | 2.25 | 2,500 | 5,625 | 2,500 | |
Oct 06 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | J | 4.05 | 2,500 | 10,125 | 2,500 | |
Oct 06 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | J | 3.73 | 2,500 | 9,325 | 2,500 | |
Oct 06 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | J | 10.46 | 2,500 | 26,150 | 2,500 | |
Oct 06 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | J | 12.16 | 2,500 | 30,400 | 2,500 | |
Oct 06 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | J | 8.37 | 1,875 | 15,694 | 1,875 | |
Oct 06 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | J | 5.00 | 12,500 | 62,500 | 12,500 | |
Aug 20 2009 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 2.24 | 50,000 | 112,000 | 50,000 | |
Aug 20 2009 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | SVP, Drug Developme ... | Option Exercise | A | 2.24 | 35,000 | 78,400 | 35,000 | |
Aug 20 2009 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | SVP, Legal Affairs ... | Option Exercise | A | 2.24 | 25,000 | 56,000 | 25,000 | |
Aug 20 2009 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | SVP, Legal Affairs ... | Option Exercise | A | 2.24 | 75,000 | 168,000 | 75,000 | |
Aug 20 2009 | ANDS | ANADYS PHARMACEUTI ... | Slover Peter T | VP, Finance and Ope ... | Option Exercise | A | 2.24 | 25,000 | 56,000 | 25,000 | |
May 29 2009 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
May 29 2009 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
May 29 2009 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
May 29 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
May 29 2009 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
May 29 2009 | ANDS | ANADYS PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
Dec 12 2008 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Option Exercise | A | 1.99 | 75,000 | 149,250 | 75,000 | |
Dec 12 2008 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Vice President, Leg ... | Option Exercise | A | 1.99 | 75,000 | 149,250 | 75,000 | |
Dec 12 2008 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Option Exercise | A | 1.99 | 75,000 | 149,250 | 75,000 | |
Dec 12 2008 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | SVP, Drug Developme ... | Option Exercise | A | 1.99 | 100,000 | 199,000 | 100,000 | |
Dec 12 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 1.99 | 100,000 | 199,000 | 100,000 | |
Oct 21 2008 | ANDS | ANADYS PHARMACEUTI ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 136,907 | 298,457 | 904,903 | 1 M to 904.9 K (-13.14 %) |
Oct 21 2008 | ANDS | ANADYS PHARMACEUTI ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 74,693 | 162,831 | 493,713 | 568.4 K to 493.7 K (-13.14 %) |
Oct 21 2008 | ANDS | ANADYS PHARMACEUTI ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 157,486 | 343,319 | 1,077,165 | 1.2 M to 1.1 M (-12.76 %) |
Oct 21 2008 | ANDS | ANADYS PHARMACEUTI ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 90,914 | 198,193 | 659,711 | 750.6 K to 659.7 K (-12.11 %) |
Aug 28 2008 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Buy | P | 2.70 | 10,000 | 27,000 | 33,188 | 23.2 K to 33.2 K (+43.13 %) |
Aug 06 2008 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | SVP, Drug Developme ... | Option Exercise | A | 2.74 | 50,000 | 137,000 | 50,000 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | M | 2.95 | 16,200 | 47,790 | 70,075 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | M | 2.95 | 17,651 | 52,070 | 37,249 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | M | 2.95 | 47 | 139 | 136,530 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | M | 2.95 | 16,200 | 47,790 | 72,317 | 56.1 K to 72.3 K (+28.87 %) |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | M | 2.95 | 17,651 | 52,070 | 56,117 | 38.5 K to 56.1 K (+45.89 %) |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | M | 2.95 | 47 | 139 | 38,466 | 38.4 K to 38.5 K (+0.12 %) |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.73 | 15,000 | 40,950 | 15,000 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 2.73 | 15,000 | 40,950 | 15,000 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Option Exercise | A | 2.73 | 15,000 | 40,950 | 15,000 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 2.73 | 15,000 | 40,950 | 15,000 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 2.73 | 15,000 | 40,950 | 15,000 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 2.73 | 15,000 | 40,950 | 15,000 | |
May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 2.73 | 15,000 | 40,950 | 15,000 | |
Dec 11 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 2.00 | 75,000 | 150,000 | 75,000 | |
Dec 11 2007 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Option Exercise | A | 2.00 | 50,000 | 100,000 | 50,000 | |
Dec 11 2007 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | Chief Medical Offic ... | Option Exercise | A | 2.00 | 50,000 | 100,000 | 50,000 | |
Dec 11 2007 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Vice President, Leg ... | Option Exercise | A | 2.00 | 40,000 | 80,000 | 40,000 | |
Dec 11 2007 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Option Exercise | A | 2.00 | 40,000 | 80,000 | 40,000 | |
Dec 11 2007 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Option Exercise | A | 2.32 | 75,000 | 174,000 | 75,000 | |
Nov 19 2007 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Buy | P | 2.00 | 600 | 1,200 | 5,000 | 4.4 K to 5 K (+13.64 %) |
Nov 19 2007 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Buy | P | 2.05 | 200 | 410 | 4,400 | 4.2 K to 4.4 K (+4.76 %) |
Nov 19 2007 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Buy | P | 2.10 | 1,000 | 2,100 | 4,200 | 3.2 K to 4.2 K (+31.25 %) |
Nov 13 2007 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Buy | P | 2.10 | 3,401 | 7,142 | 9,170 | 5.8 K to 9.2 K (+58.95 %) |
Nov 13 2007 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Buy | P | 2.10 | 1,599 | 3,358 | 5,769 | 4.2 K to 5.8 K (+38.35 %) |
Sep 14 2007 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Buy | P | 2.30 | 2,869 | 6,599 | 814,206 | 811.3 K to 814.2 K (+0.35 %) |
Sep 10 2007 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Buy | P | 2.30 | 200 | 460 | 811,337 | 811.1 K to 811.3 K (+0.02 %) |
Sep 10 2007 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Vice President, Leg ... | Option Exercise | A | 2.32 | 75,000 | 174,000 | 75,000 | |
Sep 10 2007 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Option Exercise | A | 2.32 | 75,000 | 174,000 | 75,000 | |
Sep 10 2007 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | Chief Medical Offic ... | Option Exercise | A | 2.32 | 100,000 | 232,000 | 100,000 | |
Sep 10 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 2.32 | 100,000 | 232,000 | 100,000 | |
Sep 10 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Option Exercise | A | 2.32 | 100,000 | 232,000 | 100,000 | |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | WILLIAMS DOUGLAS E | Director | Buy | P | 2.36 | 2,000 | 4,720 | 4,500 | 2.5 K to 4.5 K (+80.00 %) |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Buy | P | 2.21 | 200 | 442 | 23,188 | 23 K to 23.2 K (+0.87 %) |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Buy | P | 2.15 | 1,091 | 2,346 | 22,988 | 21.9 K to 23 K (+4.98 %) |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Buy | P | 2.19 | 2,200 | 4,818 | 21,897 | 19.7 K to 21.9 K (+11.17 %) |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Buy | P | 2.20 | 2,688 | 5,914 | 19,697 | 17 K to 19.7 K (+15.80 %) |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Buy | P | 2.22 | 5,600 | 12,432 | 17,009 | 11.4 K to 17 K (+49.08 %) |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Buy | P | 2.14 | 10,409 | 22,275 | 11,409 | 1,000 to 11.4 K (+1,040.90 %) |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Buy | P | 2.30 | 89,333 | 205,466 | 811,137 | 721.8 K to 811.1 K (+12.38 %) |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Buy | P | 2.22 | 32,913 | 73,116 | 721,804 | 688.9 K to 721.8 K (+4.78 %) |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.25 | 2,500 | 5,625 | 2,500 | |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 2.25 | 5,000 | 11,250 | 5,000 | |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Option Exercise | A | 2.25 | 5,000 | 11,250 | 5,000 | |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 2.25 | 5,000 | 11,250 | 5,000 | |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 2.25 | 5,000 | 11,250 | 5,000 | |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 2.25 | 5,000 | 11,250 | 5,000 | |
Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 2.25 | 5,000 | 11,250 | 5,000 | |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.34 | 895 | 2,094 | 208,704 | 207.8 K to 208.7 K (+0.43 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.35 | 12,341 | 29,001 | 207,809 | 195.5 K to 207.8 K (+6.31 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.15 | 19 | 41 | 195,468 | 195.4 K to 195.5 K (+0.01 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.13 | 1,042 | 2,219 | 195,449 | 194.4 K to 195.4 K (+0.54 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.10 | 1,800 | 3,780 | 194,407 | 192.6 K to 194.4 K (+0.93 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.08 | 3,120 | 6,490 | 192,607 | 189.5 K to 192.6 K (+1.65 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.12 | 6,219 | 13,184 | 189,487 | 183.3 K to 189.5 K (+3.39 %) |
Sep 04 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President and CEO | Buy | P | 2.00 | 124,564 | 249,128 | 183,268 | 58.7 K to 183.3 K (+212.19 %) |
Aug 17 2007 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Buy | P | 2.15 | 38,989 | 83,826 | 688,891 | 649.9 K to 688.9 K (+6.00 %) |
Aug 16 2007 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | Director | Buy | P | 2.15 | 6,500 | 13,957 | 177,144 | 170.6 K to 177.1 K (+3.81 %) |
Aug 16 2007 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Buy | P | 2.17 | 1,000 | 2,169 | 4,170 | 3.2 K to 4.2 K (+31.55 %) |
Aug 15 2007 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | Chief Medical Offic ... | Buy | P | 2.25 | 5,000 | 11,250 | 13,000 | 8 K to 13 K (+62.50 %) |